This site is intended for healthcare professionals
Unrecognizable female doctor holding graphic virtual visualization model of Lungs organ in hands. Multiple medical icons on the background.
Expanding Your Understanding of Type 2 inflammation in COPD
Declaration of sponsorship Sanofi and Regeneron Pharmaceuticals, Inc.

Type 2 Inflammation in COPD

Declaration of sponsorship Sanofi and Regeneron Pharmaceuticals, Inc.
Last updated:13th Jun 2024
Published:13th Jun 2024

COPD is a chronic, heterogeneous, and often progressive inflammatory airway disease that leads to reduced health-related quality of life in patients. Discover more about COPD with type 2 inflammation through a broad selection of medical resources.

  • Review the pathophysiologic processes underlying COPD and its clinical consequences
  • Understand the complexity and heterogeneous inflammatory pathways involved in COPD 
  • Gain insights into the burden of type 2 inflammation in COPD patients 
  • Learn about the key differences between asthma and COPD
Welcome: